Acute Treatment of Cerebral Edema in Neurocritical Care Patients

Publication Date: June 1, 2020
Last Updated: March 14, 2022

Recommendations

Treatment of Cerebral Edema in Patients with Subarachnoid Hemorrhage

1. We suggest using symptom-based bolus dosing of hypertonic sodium solutions rather than sodium target-based dosing for the management of ICP or cerebral edema in patients with SAH (conditional recommendation, very low-quality evidence)
Rationale: In making this recommendation, the panel felt that while the quality of evidence was very low, the consistency of the literature justifed symptom-based bolus dosing of HTS as an efective means of reducing ICP and cerebral edema in patients with SAH. Te data on sodium target-based HTS dosing regimens for ICP control were extremely limited and provided only indirect evidence and thus could not be recommended.
6731

Overview

Title

Acute Treatment of Cerebral Edema in Neurocritical Care Patients

Authoring Organization